What the latest Johnson & Johnson COVID vaccine data really means
By DR. ERIC SILBERMAN, ABC News
(NEW YORK) -- Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by... Read More.